【结 构 式】 |
【分子编号】31095 【品名】4-fluorobenzylamine; (4-fluorophenyl)methanamine 【CA登记号】140-75-0 |
【 分 子 式 】C7H8FN 【 分 子 量 】125.1456632 【元素组成】C 67.18% H 6.44% F 15.18% N 11.19% |
合成路线1
该中间体在本合成路线中的序号:(III)The reaction of 2,6-dichloro-3-nitropyridine (I) with ammonia yields 2-amino-3-nitro-chloropyridine (II). 4-Fluorobenzylamine (III) reacts in dioxane and in the presence of triethylamine with (II), resulting in the 2-amino-3-nitro-6-p-fluorobenzylamine derivative (IV). The latter is hydrated and in situ the 3-amino group is condensed with ethyl chloroformate leading to the stable 2-amino-3-carbethoxyamino-6-(p-fluorobenzylamino)pyridine (Flupirtine).
【1】 Thiele, K.; Steinmetz, G.; Bebenburg, W.v.; Chem Ztg 1979, 103, 10, 387. |
【2】 Bebenburg, W.v.; Engel, J.; Sheldrick, W.S.; Thiele, K.; Chem Ztg 1981, 105, 10, 217. |
【3】 Castaner, J.; Serradell, M.N.; Blancafort, P.; Flupirtine. Drugs Fut 1983, 8, 9, 773. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 13574 | 2,6-Dichloro-3-nitropyridine | 16013-85-7 | C5H2Cl2N2O2 | 详情 | 详情 |
(II) | 13575 | 6-Chloro-3-nitro-2-pyridinamine; 2-Amino-6-chloro-3-nitropyridine; 6-Chloro-3-nitro-2-pyridinylamine | 27048-04-0 | C5H4ClN3O2 | 详情 | 详情 |
(III) | 31095 | 4-fluorobenzylamine; (4-fluorophenyl)methanamine | 140-75-0 | C7H8FN | 详情 | 详情 |
(IV) | 13576 | N(6)-(4-Fluorobenzyl)-3-nitro-2,6-pyridinediamine; N-(6-Amino-5-nitro-2-pyridinyl)-N-(4-fluorobenzyl)amine | C12H11FN4O2 | 详情 | 详情 | |
(V) | 13577 | N(6)-(4-Fluorobenzyl)-2,3,6-pyridinetriamine; 2-Amino-6-[(4-fluorobenzyl)amino]-3-pyridinylamine | C12H13FN4 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:D-19050 can be obtained in a 5-step synthesis starting from 2,6-dichloropyridine (I): Compound (I) is nitrated with HNO3/H2SO4 yielding 2,6-dichloro-3-nitropyridine (II). Subsequent reaction with ammonia and 4-fluorobenzylamine leads to 2-amino-3-nitro-6-(4-fluorobenzylamino)pyridine (IV), which is hydrogenated using Raney Nickel as catalyst to the corresponding 3-amino derivative (V). This is not isolated, but reacted with (prop-1-en-3-yl)chloroformate to give D-19050.
【1】 Engel, J.; Emig, P.; Szelenyi, I.; Nickel, B.; Weischer, K.H.; D-19050. Drugs Fut 1989, 14, 6, 511. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
31095 | 4-fluorobenzylamine; (4-fluorophenyl)methanamine | 140-75-0 | C7H8FN | 详情 | 详情 | |
(I) | 13573 | 2,6-Dichloropyridine | 2402-78-0 | C5H3Cl2N | 详情 | 详情 |
(II) | 13574 | 2,6-Dichloro-3-nitropyridine | 16013-85-7 | C5H2Cl2N2O2 | 详情 | 详情 |
(III) | 13575 | 6-Chloro-3-nitro-2-pyridinamine; 2-Amino-6-chloro-3-nitropyridine; 6-Chloro-3-nitro-2-pyridinylamine | 27048-04-0 | C5H4ClN3O2 | 详情 | 详情 |
(IV) | 13576 | N(6)-(4-Fluorobenzyl)-3-nitro-2,6-pyridinediamine; N-(6-Amino-5-nitro-2-pyridinyl)-N-(4-fluorobenzyl)amine | C12H11FN4O2 | 详情 | 详情 | |
(V) | 13577 | N(6)-(4-Fluorobenzyl)-2,3,6-pyridinetriamine; 2-Amino-6-[(4-fluorobenzyl)amino]-3-pyridinylamine | C12H13FN4 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:D-19274 can be obtained in a 6-step synthesis starting from 2,6-dichloropyridine (I). Compound (I) is nitrated with HNO3/H2SO4 yielding 2,6-dichloro-3-nitropyridine (II). Subsequent reaction with ammonia and 4-fluorobenzylamine leads to 2-amino-3-nitro-6-(4-fluorobenzylamino)pyridine (IV), which is hydrogenated using Raney Nickel as catalyst to the corresponding 3-amino derivative (V), which reacts with 2-bromoethyl chloroformate to 2-bromoethyl [N-(2-amino-6-(4-fluorobenzylamino)pyridin-3-yl)]carbamate hydrochloride (VI). (VI) is then treated with excess NaOH at 35 C, followed by treatment with isopropanol HCl to give the desired D-19274.
【1】 Engel, J.; Emig, P.; Nickel, B.; Szelenyi, I. (Asta Medica AG); 3-(N-heterocyclyl)-2,6-diaminopyridines and N-oxides, their preparation and their use as medicines. DE 3915184; EP 0343429; JP 1990017186; US 4923858 . |
【2】 Emig, P.; Engel, J.; Nickel, B.; Szelenyi, I.; Werner, U.; D-19274. Drugs Fut 1990, 15, 3, 223. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
31095 | 4-fluorobenzylamine; (4-fluorophenyl)methanamine | 140-75-0 | C7H8FN | 详情 | 详情 | |
63775 | 1-bromo-2-[(chlorocarbonyl)oxy]ethane | C3H4BrClO2 | 详情 | 详情 | ||
(I) | 13573 | 2,6-Dichloropyridine | 2402-78-0 | C5H3Cl2N | 详情 | 详情 |
(II) | 13574 | 2,6-Dichloro-3-nitropyridine | 16013-85-7 | C5H2Cl2N2O2 | 详情 | 详情 |
(III) | 13575 | 6-Chloro-3-nitro-2-pyridinamine; 2-Amino-6-chloro-3-nitropyridine; 6-Chloro-3-nitro-2-pyridinylamine | 27048-04-0 | C5H4ClN3O2 | 详情 | 详情 |
(IV) | 13576 | N(6)-(4-Fluorobenzyl)-3-nitro-2,6-pyridinediamine; N-(6-Amino-5-nitro-2-pyridinyl)-N-(4-fluorobenzyl)amine | C12H11FN4O2 | 详情 | 详情 | |
(V) | 13577 | N(6)-(4-Fluorobenzyl)-2,3,6-pyridinetriamine; 2-Amino-6-[(4-fluorobenzyl)amino]-3-pyridinylamine | C12H13FN4 | 详情 | 详情 | |
(VI) | 13578 | 2-bromoethyl 2-amino-6-[(4-fluorobenzyl)amino]-3-pyridinylcarbamate | C15H16BrFN4O2 | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(V)Nitration of 3-chlorobenzoic acid (I) with KNO3 and H2SO4 produced 2,4-dinitro-5-chlorobenzoic acid (II) which, after conversion to acid chloride (III), was reacted with ammonia to give amide (IV). Displacement of the chlorine of (IV) with 4-fluorobenzylamine (V) furnished aminobenzamide (VI). The nitro groups were then reduced by hydrogenation over PtO2, and the resulting triamine (VII) was cyclized to benzimidazole (VIII) by means of formic acid. 5-Bromo-2-propoxybenzoic acid (X) was prepared from 5-bromosalicylic acid (IX) by alkylation with n-propyl iodide. Coupling of carboxylic acid (X) with amine (VIII) using EDC and HOBt afforded amide (XI), which was cyclized to the imidazoquinazoline (XII) in the presence of potassium tert-butoxide. Substitution of the bromine atom of (XII) with cuprous cyanide in NMP yielded nitrile (XIII). This was finally converted to the desired amide by hydrolysis to the carboxylic acid, followed by coupling with ammonia in the presence of EDC.
【1】 Normandin, D.; Zhu, Y.; Rotella, D.P.; Sun, Z.; Macor, J.E.; Seliger, L.; Krupinski, J.; Pongrac, R.; N-3-Substituted imidazoquinazolinones: Potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction. J Med Chem 2000, 43, 7, 1257. |
【2】 Weller, H.N. III; Rotella, D.P.; Yevich, J.P.; Cushman, D.W.; Macor, J.E. (Bristol-Myers Squibb Co.); Quinazolinone inhibitors of cGMP phosphodiesterase. US 6087368; WO 9964004 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 38849 | m-chlorobenzoic acid; 3-chlorobenzoic acid | 535-80-8 | C7H5ClO2 | 详情 | 详情 |
(II) | 38850 | 5-chloro-2,4-dinitrobenzoic acid | C7H3ClN2O6 | 详情 | 详情 | |
(III) | 38851 | 5-chloro-2,4-dinitrobenzoyl chloride | C7H2Cl2N2O5 | 详情 | 详情 | |
(IV) | 38852 | 5-chloro-2,4-dinitrobenzamide | C7H4ClN3O5 | 详情 | 详情 | |
(V) | 31095 | 4-fluorobenzylamine; (4-fluorophenyl)methanamine | 140-75-0 | C7H8FN | 详情 | 详情 |
(VI) | 38853 | 5-[(4-fluorobenzyl)amino]-2,4-dinitrobenzamide | C14H11FN4O5 | 详情 | 详情 | |
(VII) | 38854 | 2,4-diamino-5-[(4-fluorobenzyl)amino]benzamide | C14H15FN4O | 详情 | 详情 | |
(VIII) | 38855 | 5-amino-1-(4-fluorobenzyl)-1H-benzimidazole-6-carboxamide | C15H13FN4O | 详情 | 详情 | |
(IX) | 38856 | 5-bromo-2-hydroxybenzoic acid | 89-55-4 | C7H5BrO3 | 详情 | 详情 |
(X) | 38857 | 5-bromo-2-propoxybenzoic acid | C10H11BrO3 | 详情 | 详情 | |
(XI) | 38858 | 5-[(5-bromo-2-propoxybenzoyl)amino]-1-(4-fluorobenzyl)-1H-benzimidazole-6-carboxamide | C25H22BrFN4O3 | 详情 | 详情 | |
(XII) | 38859 | 6-(5-bromo-2-propoxyphenyl)-1-(4-fluorobenzyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one | C25H20BrFN4O2 | 详情 | 详情 | |
(XIII) | 38860 | 3-[1-(4-fluorobenzyl)-8-oxo-7,8-dihydro-1H-imidazo[4,5-g]quinazolin-6-yl]-4-propoxybenzonitrile | C26H20FN5O2 | 详情 | 详情 |
合成路线5
该中间体在本合成路线中的序号:(XIII)The pyrazolopyridopyrimidine tricyclic system (XII) was generated by acylation of amine (X) with acid chloride (XI), followed by base-mediated cyclization. Displacement of the remaining chloride of (XII) with p-fluorobenzyl amine (XIII) afforded (XIV). The p-methoxybenzyl group of (XIV) was finally removed by treatment with trifluoroacetic acid yielding the title compound.
【1】 Bi, Y.; et al.; The discovery of novel, potent and selective PDE5 inhibitors. Bioorg Med Chem Lett 2001, 11, 18, 2461. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(X) | 51148 | 4-amino-6-chloro-2-(4-methoxybenzyl)-2H-pyrazolo[3,4-b]pyridine-5-carboxamide | C15H14ClN5O2 | 详情 | 详情 | |
(XI) | 51149 | 5-[[(3R)-3-(dimethylamino)pyrrolidinyl]sulfonyl]-2-propoxybenzoyl chloride | C16H23ClN2O4S | 详情 | 详情 | |
(XII) | 51150 | 5-chloro-2-(5-[[(3R)-3-(dimethylamino)pyrrolidinyl]sulfonyl]-2-propoxyphenyl)-8-(4-methoxybenzyl)-3,8-dihydro-4H-pyrazolo[4',3':5,6]pyrido[4,3-d]pyrimidin-4-one | C31H34ClN7O5S | 详情 | 详情 | |
(XIII) | 31095 | 4-fluorobenzylamine; (4-fluorophenyl)methanamine | 140-75-0 | C7H8FN | 详情 | 详情 |
(XIV) | 51151 | 2-(5-[[(3R)-3-(dimethylamino)pyrrolidinyl]sulfonyl]-2-propoxyphenyl)-5-[(4-fluorobenzyl)amino]-8-(4-methoxybenzyl)-3,8-dihydro-4H-pyrazolo[4',3':5,6]pyrido[4,3-d]pyrimidin-4-one | C38H41FN8O5S | 详情 | 详情 |
合成路线6
该中间体在本合成路线中的序号:(VI)Mitsunobu coupling between isopropyl 3-(hydroxymethyl)pyridine-2-carboxylate (I) and N-tosyl glycine methyl ester (II) affords amino diester (III). Diester (III) is subsequently converted to the naphthyridine (IV) under Dieckmann cyclization conditions. Bromination of naphthyridine (IV) by means of N-bromosuccinimide provides (V). The methyl ester group of (V) is then displaced with 4-fluorobenzylamine (VI) to furnish amide (VII). Finally, copper-catalyzed displacement of the bromide (VII) with butanesultam (VIII) provides the title compound.
【1】 Young, S.D.; Guare, J.P.; Wai, J.S.; Fisher, T.E.; Perlow, D.S.; Anthony, N.J.; Egbertson, M.; Gomez, R.P.; Kuo, M.S.; Tran, L.; Zhuang, L.; Langford, H.M.; Melamed, J.Y.; Bennett, J.J.; Embrey, M.; Jolly, S.M.; Funk, T.W. (Merck & Co., Inc.); Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors. WO 0230930; WO 0230931 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 57743 | isopropyl 3-(hydroxymethyl)-2-pyridinecarboxylate | C10H13NO3 | 详情 | 详情 | |
(II) | 57744 | methyl 2-{[(4-methylphenyl)sulfonyl]amino}acetate | 2645-02-5 | C10H13NO4S | 详情 | 详情 |
(III) | 57745 | isopropyl 3-({(2-methoxy-2-oxoethyl)[(4-methylphenyl)sulfonyl]amino}methyl)-2-pyridinecarboxylate | C20H24N2O6S | 详情 | 详情 | |
(IV) | 57746 | methyl 8-hydroxy[1,6]naphthyridine-7-carboxylate | C10H8N2O3 | 详情 | 详情 | |
(V) | 57747 | methyl 5-bromo-8-hydroxy[1,6]naphthyridine-7-carboxylate | C10H7BrN2O3 | 详情 | 详情 | |
(VI) | 31095 | 4-fluorobenzylamine; (4-fluorophenyl)methanamine | 140-75-0 | C7H8FN | 详情 | 详情 |
(VII) | 57748 | 5-bromo-N-(4-fluorobenzyl)-8-hydroxy[1,6]naphthyridine-7-carboxamide | C16H11BrFN3O2 | 详情 | 详情 | |
(VIII) | 57749 | 1lambda~6~,2-thiazinane-1,1-dione | C4H9NO2S | 详情 | 详情 |